SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-035548
Filing Date
2022-03-18
Accepted
2022-03-18 16:05:50
Documents
12
Period of Report
2022-03-16
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm229779d1_8k.htm   iXBRL 8-K 27880
  Complete submission text file 0001104659-22-035548.txt   201947

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA axla-20220316.xsd EX-101.SCH 3048
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE axla-20220316_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axla-20220316_pre.xml EX-101.PRE 22605
6 EXTRACTED XBRL INSTANCE DOCUMENT tm229779d1_8k_htm.xml XML 3593
Mailing Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139 617-868-0949
Axcella Health Inc. (Filer) CIK: 0001633070 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38901 | Film No.: 22752531
SIC: 2836 Biological Products, (No Diagnostic Substances)